Perpetual Ltd’s Neurocrine Biosciences NBIX Stock Holding History

Perpetual Ltd’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$480K	Sell	2,846 -513	-15%	-$76.1K	0.01%	331
2026 Q1	$443K	Buy	3,359 +620	+23%	+$82.3K	0.01%	333
2025 Q4	$388K	Buy	+2,739	New	+$397K	0.01%	339
2025 Q3	–	Sell	-2,930	Closed	-$368K	–	435
2025 Q2	$368K	Hold	2,930	–	–	﹤0.01%	357
2025 Q1	$324K	Sell	2,930 -10,171	-78%	-$1.29M	﹤0.01%	367
2024 Q4	$1.79M	Buy	13,101 +541	+4%	+$66.9K	0.02%	201
2024 Q3	$1.45M	Buy	12,560 +6,170	+97%	+$846K	0.02%	224
2024 Q2	$880K	Sell	6,390 -410	-6%	-$56.2K	0.01%	283
2024 Q1	$938K	Buy	6,800 +14	+0.2%	+$1.91K	0.01%	286
2023 Q4	$894K	Buy	+6,786	New	+$781K	0.01%	285
2023 Q3	–	Sell	-2,268	Closed	-$214K	–	486
2023 Q2	$214K	Buy	+2,268	New	+$222K	﹤0.01%	454

Other funds holding NBIX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PBBUPS

PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return

Aware Super Sydney, Australia $7.06B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Perpetual Ltd's NBIX Position: Q2 2026 in Review

Perpetual Ltd reduced its Neurocrine Biosciences (NBIX) stake by 15% in Q2 2026, selling an estimated $76.1K and leaving 2,846 shares worth $480K. The position accounts for 0.01% of the portfolio, ranked #331.

Perpetual Ltd first reported a position in NBIX in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.79M in Q4 2024. 226 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

Perpetual Ltd held 2,846 shares of Neurocrine Biosciences worth $480K as of Q2 2026.
Perpetual Ltd sold 513 Neurocrine Biosciences shares in Q2 2026, an estimated $76.1K.
Neurocrine Biosciences made up 0.01% of Perpetual Ltd's portfolio in Q2 2026, its #331 holding.
Perpetual Ltd first reported a position in Neurocrine Biosciences in Q2 2023 and has held it in 11 quarters since.
Perpetual Ltd's Neurocrine Biosciences position peaked at $1.79M in Q4 2024.
226 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.